03/24/2025
6:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/24/2025
6:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
3:30 PM | Moleculin Biotech (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2025
4:15 PM | Moleculin Biotech (Filer)
| Form DEF 14A | |
03/13/2025
4:15 PM | Moleculin Biotech (Filer)
| Form DEF 14A | |
03/06/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
9:09 AM | Moleculin Biotech (Filer)
| Form 424B5 | |
02/24/2025
4:16 PM | Moleculin Biotech (Filer)
| Form RW | |
02/14/2025
4:51 PM | ARMISTICE CAPITAL, LLC (Filed by)
Moleculin Biotech (Subject)
| Form SCHEDULE 13G/A | |
02/13/2025
3:17 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2025
8:25 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MBRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Moleculin Biotech and its competitors with MarketBeat's FREE daily newsletter. |
02/11/2025
8:25 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2025
7:31 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
02/10/2025
7:32 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
02/10/2025
7:33 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/29/2025
8:18 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
01/27/2025
11:08 AM | Moleculin Biotech (Filer)
| Form 8-K/A | |
01/27/2025
8:16 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:02 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/11/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
12/03/2024
4:20 PM | Moleculin Biotech (Filer)
| Form POS AM | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
7:20 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
4:09 PM | Moleculin Biotech (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:00 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | CANNON MICHAEL D (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:03 PM | George Robert E. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:04 PM | Climaco John M (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:05 PM | Cermak Elizabeth (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
7:06 PM | Moleculin Biotech (Issuer)
Yan Joy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:27 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump’s Treasure Map [Pic inside] (Ad) We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America.
Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking.
And he believes Trump could soon release this frozen asset to the public.
 But something even more spectacular is bound to happen. And those who know what to expect could make |
10/25/2024
3:43 PM | Moleculin Biotech (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/25/2024
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:40 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
7:15 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2024
4:15 PM | Moleculin Biotech (Filer)
| Form PRE 14A | |
08/19/2024
3:10 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
9:06 AM | Moleculin Biotech (Filer)
| Form 424B3 | |
08/16/2024
3:54 PM | Moleculin Biotech (Filer)
| Form 424B4 | |
08/15/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
08/15/2024
10:21 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024
8:57 PM | Moleculin Biotech (Filer)
| Form S-1/A | |
08/14/2024
7:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
8:05 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
7:35 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
6:00 AM | Moleculin Biotech (Filer)
| Form S-1/A | |
07/22/2024
4:31 PM | Moleculin Biotech (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2024
4:01 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2024
11:15 PM | Moleculin Biotech (Filer)
| Form EFFECT | |
06/25/2024
5:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:01 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:02 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:00 PM | KLEMP WALTER V (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:01 PM | Foster Jonathan P. (Reporting)
Moleculin Biotech (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2024
4:01 PM | Moleculin Biotech (Issuer)
PICKER DONALD H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
7:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2024
4:05 PM | Moleculin Biotech (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/16/2024
7:32 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
7:38 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:16 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
6:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
7:31 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
7:55 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
8:00 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
4:15 PM | Moleculin Biotech (Filer)
| Form 10-K/A | |
04/25/2024
7:23 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/18/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2024
7:30 AM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
4:14 PM | Moleculin Biotech (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
